Believability of messaging concerning a hypothetical product standard to lower a constituent in cigarettes or smokeless tobacco among U.S. Adults who use tobacco
- PMID: 38169982
- PMCID: PMC10758972
- DOI: 10.1016/j.pmedr.2023.102544
Believability of messaging concerning a hypothetical product standard to lower a constituent in cigarettes or smokeless tobacco among U.S. Adults who use tobacco
Abstract
The U.S. Food and Drug Administration (FDA) has regulatory authority to implement tobacco product standards to reduce harmful and potentially harmful constituents (HPHCs). This study examines people who use tobacco products' awareness of FDA's tobacco regulatory authority, knowledge of HPHCs, and belief in hypothetical tobacco product standard statements. We recruited adults who reported currently using tobacco (N = 1,592) from the National Panel of Tobacco Consumer Studies and randomized them to one of four conditions. Participants viewed a stimulus which consisted of a statement about a hypothetical product standard that would reduce the level of a chemical in cigarettes or smokeless tobacco (ST) and reduce cases of cancer or heart attack and stroke. A small majority of participants correctly believed that FDA regulates tobacco; however, the percentage of participants who recognized HPHCs varied widely depending upon the chemical. People who currently use ST found chemical and health statements more believable than people who did not currently use ST. Participants found it more believable that cigarettes, not ST, could be made with fewer harm-causing chemicals, and their belief in the chemical and health statements did not differ based on the health outcome specified in the hypothetical product standard statement.
Keywords: Believability; Cigarettes; Harmful and potentially harmful constituents; Regulatory authority; Smokeless tobacco; Tobacco product standard.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs).BMC Chem. 2023 Mar 3;17(1):9. doi: 10.1186/s13065-023-00918-1. BMC Chem. 2023. PMID: 36869349 Free PMC article.
-
Harmful and Potentially Harmful Constituents in the Filler and Smoke of Tobacco-Containing Tobacco Products.ACS Omega. 2022 Jul 11;7(29):25537-25554. doi: 10.1021/acsomega.2c02646. eCollection 2022 Jul 26. ACS Omega. 2022. PMID: 35910156 Free PMC article.
-
Believability of Cigarette Warnings About Addiction: National Experiments of Adolescents and Adults.Nicotine Tob Res. 2018 Jun 7;20(7):867-875. doi: 10.1093/ntr/ntx185. Nicotine Tob Res. 2018. PMID: 29059352 Free PMC article.
-
Smokeless tobacco use: harm reduction or induction approach?Prev Med. 2004 Mar;38(3):309-17. doi: 10.1016/j.ypmed.2003.10.006. Prev Med. 2004. PMID: 14766113 Review.
-
Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.Am J Prev Med. 2007 Dec;33(6 Suppl):S379-86. doi: 10.1016/j.amepre.2007.09.015. Am J Prev Med. 2007. PMID: 18021913 Review.
References
-
- Ashley D.L., Backinger C.L., van Bemmel D.M., Neveleff D.J. Tobacco regulatory science: research to inform regulatory action at the food and drug administration's center for tobacco products. Nicotine Tob Res. 2014;16(8):1045–1049. - PubMed
-
- Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Stat. Soc.: Ser. B (Methodol.) 1995;57(1):289–300.
LinkOut - more resources
Full Text Sources